Clinical Trial: Persistence of the Immune Response After Ebola Vaccine Immunisation

Study Status: Enrolling by invitation
Recruit Status: Enrolling by invitation
Study Type: Observational




Official Title: Evaluating the Long Term Immunogenicity of Ebola Virus Vaccines Ad26-ZEBOV and MVA-BN-Filo

Brief Summary: The Oxford University is undertaking a follow-on study to a Phase 1 study involving the two viral vectored Ebola vaccines Ad26-ZEBOV and MVA-BN-Filo. The aim of this study is to investigate the persistence of the vaccine induced immune response, 24 months after administration of the primary vaccination.